Olanzapine
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D2-24-R-0012
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Jason Wray jason.wray@dla.mil (215) 737-0614
- Joshua Tankel joshua.tankel@dla.mil (215) 737-2745
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Olanzapine, a pharmaceutical product. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The items to be procured include Olanzapine Tablets in various dosages and Olanzapine Orally Dissolvable Tablets in various dosages. This will be an unrestricted and fully competitive acquisition solicited under FAR Part 12 for commercial items. The current projected solicitation date is July 2024, but DLA reserves the right to issue the solicitation before or after this date.
Paragraph 2:
This solicitation will not use any set-aside designations. The contract will establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Annual usage estimates will be provided in the solicitation. There is no mention of any potential incumbents or current contractors. The solicitation and contract details do not include any information about possible award values or budget ranges.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Olanzapine. Procurement details follow.
Olanzapine Tablets 2.5MG, 7.5MG, 10MG, 15MG, and 20MG in 30 and 1000 count bottles, Olanzapine Tablets 5MG in 30, 100, and 1000 count bottles, and Olanzapine Orally Dissolvable Tablets 5MG, 10MG, 15MG, and 20MG in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Joshua Tankel (Joshua.Tankel@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is July of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Olanzapine SPE2D2-25-D-0011 Award | Award Notice | |
| Olanzapine SPE2D2-24-R-0012 Solicitation | Solicitation | |
| Olanzapine | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity